mavorixafor

Drug ingredient

CAS 558447-26-0

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 558447-26-0
US productionNot reported
Import value, 2024$111M
Top sourceIndia 28%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293349 · basket

These shares come from HS customs code 293349, which covers 94 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
IN 28%IndiaCN 27%ChinaSE 12%SwedenKR 10%South KoreaGB 4%United Kingdom
1 FDA-registered drug labeler
X4 Pharmaceuticals, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • •Xolremdi
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS558447-26-0
PubChem CID11256587
DTXSIDDTXSID60971247
FormulaC21H27N5
Mol. Weight349.5 g/mol
SMILESC1CC(C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3

Data Sources

Brief citations

mavorixafor (CAS 558447-26-0) https://chemicalindependence.com/chemical/558447-26-0/ PubChem: 11256587. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/11256587 FDA National Drug Code directory: CAS 558447-26-0. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/ US Census international trade: HS 293349 for CAS 558447-26-0. Reporting year: 2024. https://usatrade.census.gov/